JP2010511877A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511877A5
JP2010511877A5 JP2009539604A JP2009539604A JP2010511877A5 JP 2010511877 A5 JP2010511877 A5 JP 2010511877A5 JP 2009539604 A JP2009539604 A JP 2009539604A JP 2009539604 A JP2009539604 A JP 2009539604A JP 2010511877 A5 JP2010511877 A5 JP 2010511877A5
Authority
JP
Japan
Prior art keywords
marker
dysfunction
cardiac dysfunction
cardiac
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009539604A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010511877A (ja
JP5388858B2 (ja
Filing date
Publication date
Priority claimed from DE102006058266A external-priority patent/DE102006058266A1/de
Application filed filed Critical
Publication of JP2010511877A publication Critical patent/JP2010511877A/ja
Publication of JP2010511877A5 publication Critical patent/JP2010511877A5/ja
Application granted granted Critical
Publication of JP5388858B2 publication Critical patent/JP5388858B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009539604A 2006-12-08 2007-12-10 ニューロフィジンを使用する心機能不全の診断および危険性の層化 Expired - Fee Related JP5388858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006058266A DE102006058266A1 (de) 2006-12-08 2006-12-08 Diagnose und Risikostratifizierung von Herzinsuffizienz mittels Neurophysin
DE102006058266.7 2006-12-08
PCT/DE2007/002215 WO2008067806A2 (de) 2006-12-08 2007-12-10 Diagnose und risikostratifizierung von herzinsuffizienz mittels neurophysin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013117577A Division JP2013210385A (ja) 2006-12-08 2013-06-04 ニューロフィジンを使用する心機能不全の診断および危険性の層化

Publications (3)

Publication Number Publication Date
JP2010511877A JP2010511877A (ja) 2010-04-15
JP2010511877A5 true JP2010511877A5 (enExample) 2011-11-24
JP5388858B2 JP5388858B2 (ja) 2014-01-15

Family

ID=39363234

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009539604A Expired - Fee Related JP5388858B2 (ja) 2006-12-08 2007-12-10 ニューロフィジンを使用する心機能不全の診断および危険性の層化
JP2013117577A Pending JP2013210385A (ja) 2006-12-08 2013-06-04 ニューロフィジンを使用する心機能不全の診断および危険性の層化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013117577A Pending JP2013210385A (ja) 2006-12-08 2013-06-04 ニューロフィジンを使用する心機能不全の診断および危険性の層化

Country Status (6)

Country Link
US (1) US20100093012A1 (enExample)
EP (1) EP2100145B1 (enExample)
JP (2) JP5388858B2 (enExample)
CN (1) CN101583874B (enExample)
DE (1) DE102006058266A1 (enExample)
WO (1) WO2008067806A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5320294B2 (ja) 2006-10-26 2013-10-23 ベー．エル．アー．ハー．エム．エス ゲーエムベーハー プロバソプレシンまたはその断片および部分ペプチド、特にコペプチンまたはニューロフィジンｉｉを使用する、急性冠動脈症候群についてのリスク層化
US20110262939A1 (en) * 2008-10-31 2011-10-27 B.R.A.H.M.S Gmbh Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
CA2785592A1 (en) * 2010-01-08 2011-07-14 Cavadis B.V. Determination of exosomel biomarkers for predicting cardiovascular events
EP2533052A1 (en) * 2011-06-07 2012-12-12 B.R.A.H.M.S GmbH Diagnostic use of proSomatostatin
JP5802614B2 (ja) * 2012-06-15 2015-10-28 富士フイルム株式会社 臨床情報表示装置および臨床情報表示装置の動作方法並びに臨床情報表示プログラム
JP5802615B2 (ja) * 2012-06-18 2015-10-28 富士フイルム株式会社 臨床情報表示装置および臨床情報表示装置の動作方法並びに臨床情報表示プログラム
US10415094B2 (en) 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305142D0 (en) * 1993-03-12 1993-04-28 Medinnova Sf Method
AU2002349513B2 (en) * 2001-11-26 2007-10-18 Asubio Pharma Co., Ltd. Medicinal compositions for nasal absorption
MXPA03004105A (es) * 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
DE60335387D1 (de) * 2002-07-16 2011-01-27 Woomera Therapeutics Inc Zusammensetzungen und deren verwendungen zur identifizierung und zum targetting von provasopressinexprimierenden krebszellen
EP1530047A1 (en) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
EP2302395B1 (en) * 2006-06-07 2015-04-15 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
JP5320294B2 (ja) * 2006-10-26 2013-10-23 ベー．エル．アー．ハー．エム．エス ゲーエムベーハー プロバソプレシンまたはその断片および部分ペプチド、特にコペプチンまたはニューロフィジンｉｉを使用する、急性冠動脈症候群についてのリスク層化

Similar Documents

Publication Publication Date Title
JP5584473B2 (ja) Ｎｙｈａｉ患者についての心機能不全の診断および危険性層化のためのナトリウム利尿ペプチドのインビトロ決定
JP2010513879A5 (enExample)
JP2010507786A5 (enExample)
CN101646945B (zh) 利用CT-proET-1与NT-proBNP的组合进行急性冠状动脉综合征的诊断和风险分层
CN101568833B (zh) 使用MR-proADM的糖尿病诊断和风险分级
JP5320294B2 (ja) プロバソプレシンまたはその断片および部分ペプチド、特にコペプチンまたはニューロフィジンｉｉを使用する、急性冠動脈症候群についてのリスク層化
JP3783002B2 (ja) マーカーの組み合わせを用いた心臓疾患症例の予後判定
JP2010513880A5 (enExample)
JP2010509575A5 (enExample)
JP2010511877A5 (enExample)
Prontera et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
WO2008040328A2 (de) Diagnose von infektionen oder entzündungserkrankungen der atemwege und lunge assoziiert mit herzinsuffizienz
JP6441885B2 (ja) 脳卒中診断のためのＮＴ−ｐｒｏＡＮＰ及びＮＴ−ｐｒｏＢＮＰ
EP3279665A1 (en) Circulating esm-1 (endocan) in the assessment of atrial fibrillation
JP5388858B2 (ja) ニューロフィジンを使用する心機能不全の診断および危険性の層化
Zurek et al. Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
CN101055275A (zh) 鉴别呼吸短促的心脏和肺部起因的工具和方法
Mikheeva et al. Molecular markers for diagnostics of cardiac failure
Barbir et al. Implementation of the N-terminal proB-type Natriuretic Peptide Test in National Guidelines for Diagnosis of Heart Failure in Croatia
HK1135185B (en) Kit for diagnosis and risk stratification of cardiac insufficiency using neurophysin
HK1140544A (en) Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for nyha i patients